Yüklüyor......
Phase I study of weekly nab-paclitaxel + weekly cetuximab + intensity-modulated radiation therapy (IMRT) in patients with stage III–IVB head and neck squamous cell carcinoma (HNSCC)
BACKGROUND: There is a clinical need to improve the efficacy of standard cetuximab + concurrent intensity-modulated radiation therapy (IMRT) for patients with locally and/or regionally advanced HNSCC. Taxanes have radiosensitizing activity against HNSCC, and nab-paclitaxel may offer therapeutic adva...
Kaydedildi:
| Yayımlandı: | Ann Oncol |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Oxford University Press
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4433511/ https://ncbi.nlm.nih.gov/pubmed/24496920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdt579 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|